China Cord Blood Corp. (CO) announced its preliminary unaudited financial results for the fourth quarter ended March 31, 2012.
Net income attributable to shareholders for the fourth quarter of fiscal 2012 increased by 11.3% to RMB29.2 million or $4.6 million from RMB26.3 million in the prior year period, as a result of the preferential tax treatment of a reduced tax rate of 15%, compared to 25% in the prior year period for both Guangdong and Beijing subsidiaries.
Earnings per share for the fourth quarter of fiscal 2012 were RMB0.40 or $0.06, up from RMB0.35 last year.
Revenues for the quarter increased by 5.4% to RMB99.8 million or $15.8 million in the fourth quarter of fiscal 2012 from RMB94.7 million in the prior year period, driven by the higher processing fee per subscriber as well as growth in recurring storage revenue as the Company's accumulated subscriber base continued to expand.
For comments and feedback: editorial@rttnews.com